Related Experiment Video

Updated: Aug 12, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Therapy of penicillin-resistant pneumococcal meningitis

M T Schwartz, A R Tunkel

    Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology
    |January 1, 1995
    PubMed

    Insights

    Antimicrobial therapy for pneumococcal meningitis must adapt to rising penicillin resistance in Streptococcus pneumoniae. Current guidelines recommend third-generation cephalosporins or vancomycin based on susceptibility testing and vaccination strategies.

    Area of Science:

    • Infectious Diseases
    • Microbiology
    • Pharmacology

    Background:

    • Pneumococcal meningitis treatment is evolving due to increasing penicillin resistance in Streptococcus pneumoniae.
    • Emergence of strains with elevated minimal inhibitory concentrations (MICs) necessitates revised therapeutic approaches.

    Discussion:

    • For regions with relatively penicillin-resistant strains (MICs 0.1-1.0 µg/ml), empiric therapy with cefotaxime or ceftriaxone is advised.
    • Highly penicillin-resistant strains (MICs ≥2 µg/ml) warrant vancomycin, potentially combined with rifampin.
    • Cerebrospinal fluid (CSF) isolate susceptibility testing is crucial for guiding antimicrobial selection.

    Key Insights:

    • Penicillin G resistance patterns in Streptococcus pneumoniae are shifting, impacting meningitis treatment.
    • Third-generation cephalosporins and vancomycin are key alternatives for resistant pneumococcal meningitis.
    • Empiric therapy choices depend on local resistance prevalence and susceptibility data.

    Outlook:

    • Continued surveillance of pneumococcal susceptibility is essential for refining treatment guidelines.
    • Strict adherence to vaccination recommendations for at-risk populations can reduce infection incidence.
    • Further research may explore novel therapeutic strategies for multidrug-resistant pneumococcal meningitis.

    More Related Videos

    Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction04:25

    Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

    Published on: February 24, 2014

    Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

    Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

    Published on: April 7, 2015

    Related Concept Videos

    Production of Antibiotics01:27

    Production of Antibiotics

    Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
    Atypical Pneumonia01:14

    Atypical Pneumonia

    Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Bacterial Meningitis I: Introduction01:22

    Bacterial Meningitis I: Introduction

    Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...